Legislative Advocacy
- ASHP Comments on Draft Preliminary Framework for Equitable Allocation COVID‐19 Vaccine
- ASHP Collaborates with State Affiliates to Ask Congress for Relief to Pharmacy 501(c)(6) Non-Profits
- ASHP Thanks Senator Charles Schumer for Recognizing Pharmacists as Essential Members of the Healthcare Team
- ASHP Statement for the Record: "Vaccines Save Lives: What Is Driving Preventable Disease Outbreaks?"
- ASHP Letter Opposing Cuts to Public Health Service Commissioned Corps
- ASHP Issue Brief on Recent Legislative Activity on Opioids and Compounding
- ASHP Issue Brief The Bipartisan Budget Act of 2018 Analysis of Health Provisions
- ASHP Expresses Supports for the Overtime Reform and Enhancement Act [PDF]
- ASHP Comments to Senate Finance Committee on Chronic Care Options
Regulatory Advocacy
-
ASHP Congratulates Xavier Becerra on Appointment as Secretary of HHS [PDF]
-
ASHP Congratulates Dr. Vivek Murthy on Appointment as United States Surgeon General [PDF]
- ASHP and Other Pharmacy Organizations Submit Letter to the Biden Transition Team
- ASHP Submits Comments to CMS on Electronic Prescribing of Controlled Substances
- Breaking News: Administration Announces Health Plan, Finalizes Drug Importation, and Takes Action on Insulin and Injectable Epinephrine
- ASHP and State Affiliates Send Letter to USPS Inspector General Regarding Medication Delivery
- United States Postal Service (USPS) Slowdowns and Mail-Order Medication Delivery Delays
- ASHP Signs Joint Statement Calling for Continued Support of the World Health Organization [PDF]
- ASHP Submits Comments to OASH Regarding Long-Term Monitoring of Healthcare System Resilience
- ASHP Submits Amicus Brief to the South Carolina Charleston Division of the United States District Court Regarding Residency Programs
- ASHP Issue Brief: CMS Releases a Future LCD for Pharmacogenomics Testing
- ASHP Joins Pharmacy Organizations in Joint Response to Request from CMS Office of Minority Health [PDF]
- ASHP Requests for Improvements to Pharmacy Residency Program Oversight
- ASHP Comments to FDA Regarding Insulin Biosimilars
- ASHP Offers Input on Prescription Drug-Use Software
- ASHP Issue Brief: Biosimilar Interchangeability Guidance
- ASHP Responds to Surgeon General’s Call to Action: Community Health and Prosperity
- ASHP Comments on Proposed Changes by CMS to Drug Utilization Review and Quality Measures under Medicare Part D
- ASHP Submits Comments to HHS on Improving the Healthcare System
- ASHP Comments on Center for Medicare & Medicaid Innovation
- ASHP Comments on Request for Information on the the Center for Medicare and Medicaid Innovation
- ASHP Urges Caution on Department of Labor Overtime Rule-1
State Advocacy
- ASHP Submits Letter of Support to West Virginia Senate Bill 787
- ASHP and National Center for Frontier Communities Submit Letter of Support for New Mexico bill: the Pharmaceutical Service Reimbursement Parity (H.B. 42)
- ASHP Submits Letter of Support to New Mexico Governor Michelle Lujan Grisham on the Pharmaceutical Service Reimbursement Parity (H.B. 42)
- ASHP Submits Letter of Support to New York Governor Andrew Cuomo on Pharmacy Technician Licensure
- ASHP Submits Letter of Support to Colorado State Legislature on Technician Certification
